Clinical effects of synthetic protein anabolic steroid (HMD) upon advanced cases of pulmonarytuberculosis positive of resistant acid fast bacilli were studied from the pharmacological aspect.
1) 15 cases of advanced pulmonary tuberculosis with positive resistant strain of acid fast: bacilli but without complication were continued of the basic medication with PAS and INH, and in addition, they were administered with 15 mg/day of HMD for more than a year for thepurpose of studying its effect on body weight, sedimentation rate of erythrocyte, liver function, findings of the blood, pulmonary lesions and bacteriological findings.
2) In the humans administered with HMD, acetylating capacity for sulfa preparation, and, NEFA (nonesterified fatty acid) of the serum obtained while fasting were measured.
3) In the healthy rabbit administered with HMD, the decrease of blood sugar by theadministration of BZ 55 and the effect of HMD on the acetylation capacity of BZ 55 were.examined. Also NEFA uptake of the heart muscle in vitro was estimated from its change in, the medium.
4) Normal male rats or those treated with HMD, thyroxine or estradiol were investigated, of the isocitrate dehydrogenase activity of the 40% ammonium sulfate fraction of liver homogenatewith the addition of DPN, TPN or TPN plus DPN. The estimation was made from theincrease of the absorption spectrum at 340 mμ.
Results
1) No roentgenological and bacteriological aggravation (according to the Gakkenclassification of pulmonary tuberculosis) was observed. Gain in body weight and improvementin sedimentation rate were seen in some cases.
2) The number of red blood cells tended to increase but hemoglobin was not changed.
3) BSP showed a transient retention but returned to the normal state in the course of theobservation.
4) Acetylation capacity for sulfa preparation was decreased.
5) NEFA in the serum obtained while fasting was decreased.
6) NEFA uptake of the heart muscle of rabbit was accelerated.
7) As to the liver isocitrate dehydrogenase, DPN specific ICDH activity showed a tendency of elevation by treating with thyroxine, but no apparent difference of activity from the controlwas seen by treating with estradiol. By the treatment with HMD, both TPN specific ICDHactivity and DPN specific ICDH activity were observed to decrease, and also there was seensome effect on the transdehydrogenase activity.
Conclusion
The combined use of HMD has its significance both in suppressing the acetylation and inkeeping PAS and INH longer in effective form in the body possibly resulting in better antibacterial action.
The suppressive effect of the acetylating capacity of the drug does not seem to be causedby liver disturbance but by the changes in the matabolic patterns related to the enzymaticactivities of the liver.
View full abstract